Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture

NCT06949137 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis in Post-menopausal Women
Osteoporosis

Interventions

BIOLOGICAL: Human Umbilical Cord-derived Mesenchymal stem cell

Sponsor

HELP Therapeutics Co., Ltd.

Collaborators

[object Object]